SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 2
|
records per page:
next >
| last >>
|
| pages: 1 2
|
presentations:
1 to
50 of
92
|
GROWING UP WITH HIV (ABSTRACT
109)
Patricia M. Flynn
St. Jude Children's Research Hospital, Memphis, TN, USA
ARE WE ON THE FAST TRACK TO 'BEND AND END' THE HIV EPIDEMICS? (ABSTRACT
110)
Helen Anne Weiss
London School of Hygiene & Tropical Medicine, London, United Kingdom
ARV PROPHYLAXIS/ART INITIATION AT BIRTH LIMITS THE SIZE OF THE RESERVOIR IN CHILDREN (ABSTRACT
135)
Marta Massanella
Université de Montréal, Faculté de Médecine, Montreal, Québec, Canada
LOW HIV RESERVOIR AT 84 WEEKS IN VERY EARLY TREATED HIV-INFECTED CHILDREN IN BOTSWANA (ABSTRACT
136)
Roger L Shapiro
Harvard TH Chan School of Public Health, Boston, MA, USA
TIME TO VIRAL REBOUND AFTER STOPPING ART IN CHILDREN TREATED FROM INFANCY IN CHER (ABSTRACT
137)
Man Chan
MRC Clinical Trials Unit at UCL, London, United Kingdom
SIMILAR CLINICAL OUTCOMES BETWEEN FORMULA AND BREASTFEEDING WOMEN IN PROMISE (ABSTRACT
138)
Risa M. Hoffman
David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA
PROMISE TRIAL: RESULTS OF CONTINUED VS DISCONTINUED ART AFTER END OF BREASTFEEDING (ABSTRACT
139)
Taha E Taha
Johns Hopkins University, Baltimore, MD, USA
ART DETECTION AND RESISTANCE DURING VIRAEMIC EPISODES IN PREGNANCY AND BREASTFEEDING (ABSTRACT
140)
Landon Myer
University of Cape Town, Cape Town, South Africa
VAGINAL CONTRACEPTIVE HORMONE EXPOSURE PROFOUNDLY ALTERED BY EFV- AND ATV/R-BASED ART (ABSTRACT
141)
Kimberly K. Scarsi
University of Nebraska Medical Center, Omaha, NE, USA
RANDOMIZED TRIAL OF SAFETY OF ISONIAZID PREVENTIVE THERAPY DURING OR AFTER PREGNANCY (ABSTRACT
142LB)
Amita Gupta
RETREATMENT OF HEPATITIS C INFECTION IN PATIENTS WHO FAILED GLECAPREVIR/PIBRENTASVIR (ABSTRACT
127)
David L. Wyles
Denver Health and Hospital Authority, Denver, CO, USA
8 WEEKS OF GRAZOPREVIR/ELBASVIR FOR ACUTE HCV: A MULTICENTER CLINICAL TRIAL (DAHHS 2) (ABSTRACT
128)
Anne Boerekamps
Erasmus Medical Center, Rotterdam, Netherlands
FUELING THE EPIDEMIC: LOW RATES OF SPONTANEOUS CLEARANCE OF ACUTE HCV COINFECTION (ABSTRACT
129)
Christoph Boesecke
University Hospital Bonn, Bonn, Germany
INTERNATIONAL VERSUS DOMESTIC HCV TRANSMISSION IN MSM: A PERSPECTIVE FOR THE DAA ERA (ABSTRACT
130)
Luisa Salazar-Vizcaya
University Hospital Bern, Inselspital, Bern, Switzerland
ITAP TRIAL: MATERNAL AND INFANT EFFICACY AND SAFETY RESULTS 12 MONTHS AFTER DELIVERY (ABSTRACT
131)
Gonzague Jourdain
Institut de recherche pour le développement, Chiang Mai, Chiang Mai, Thailand
STATIN EXPOSURE IS ASSOCIATED WITH DECREASED RISK OF CANCER (ABSTRACT
132)
Roger Bedimo
VA North Texas Health Care Center, Dallas, TX, USA
PREDICTORS OF KS-IRIS IN MILD/MODERATE AIDS-KS DURING ART IN LOW-RESOURCE SETTINGS (ABSTRACT
133)
Thomas Campbell
University of Colorado Denver, Aurora, CO, USA
ACTG 5282: HPV TEST&TREAT VS CYTOLOGY-BASED CERVICAL CANCER PREVENTION IN HIV+ WOMEN (ABSTRACT
134)
Timothy Wilkin
Weill Cornell Medicine, New York, NY, USA
IDENTIFICATION OF HIV-1 ENV MUTATIONS THAT CONFER BROAD RESISTANCE TO ARVS IN VITRO (ABSTRACT
111)
Rachel Van Duyne
National Cancer Institute, Frederick, MD, USA
STRAIN-DEPENDENT ACTIVATION AND INHIBITION OF HIV-1 ENTRY BY A PF-68742 DIASTEREOMER (ABSTRACT
112)
Connie Ann Zhao
Dana Farber Cancer Institute, Boston, MA, USA
TRISPECIFIC ANTIBODIES FOR PREVENTION AND TREATMENT OF HIV-1 INFECTION (ABSTRACT
113LB)
Amarendra Pegu
Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA
MOLECULAR DETERMINANTS OF HIV HYPERMUTATION (ABSTRACT
114)
Diako Ebrahimi
University of Minnesota, Minneapolis, MN, USA
HIV-1 SPLICING SUPPRESSION AS A POSSIBLE THERAPEUTIC TARGET (ABSTRACT
115)
Ann Emery
University of North Carolina Chapel Hill, Durham, NC, USA
A LONG INTERNAL LOOP GOVERNS THE SENSITIVITY OF THE ANTI-HIV PROTEIN SERINC5 TO NEF (ABSTRACT
116)
Weiwei Dai
University of Massachusetts Medical School, Worcester, MA, USA
PROTECTIVE GENE EXPRESSION SIGNATURE IN RESPONSE TO RHCMV/SIV VACCINE VECTORS (ABSTRACT
117)
Michael Gale
University of Washington, Seattle, WA, USA
CROSS-SPECIES CMV VACCINATION REVEALS DETERMINANTS OF NON-CLASSICAL T CELLS (ABSTRACT
118)
Justin Greene
Oregon Health & Science University, Beaverton, OR, USA
HIGH UPTAKE AND REDUCED HIV-1 INCIDENCE IN AN OPEN-LABEL TRIAL OF THE DAPIVIRINE RING (ABSTRACT
143LB)
Jared Baeten
University of Washington, Seattle, WA, USA
HIV INCIDENCE AND ADHERENCE IN DREAM: AN OPEN-LABEL TRIAL OF DAPIVIRINE VAGINAL RING (ABSTRACT
144LB)
Zeda Rosenberg
International Partnership for Microbicides, Silver Spring, MD, USA
WHO REMAINS UNTESTED FOLLOWING NEAR-UNIVERSAL (>95%) POPULATION HIV TESTING? (ABSTRACT
145)
Dalsone Kwarisiima
Makerere University Joint AIDS Program , Kampala, Uganda
EXPANDED HIV TESTING ELIGIBILITY INCREASES DETECTION OF HIV INFECTIONS, WESTERN KENYA (ABSTRACT
146)
Rachael Joseph
US Centers for Disease Control and Prevention, Kisumu, Kenya, Kisumu, Kenya
OPTIMAL HIV TESTING STRATEGIES TO INCREASE HIV DIAGNOSIS IN SOUTH AFRICA (ABSTRACT
147)
Leigh F. Johnson
University of Cape Town, Cape Town, South Africa
EFFECT OF HIV SELF-TESTING ON SEXUAL PARTNER NUMBERS FOR ZAMBIAN FEMALE SEX WORKERS (ABSTRACT
148)
Catherine E Oldenburg
University of California, San Francisco, San Francisco, CA, USA
HIV SELF-TEST DISTRIBUTION INCREASES TEST FREQUENCY IN SOUTH AFRICAN MSM (ABSTRACT
149)
Sheri A. Lippman
University of California, San Francisco, San Francisco, CA, USA
LINKAGE TO CARE AFTER HIV SELF-TESTING IN ZIMBABWE: A CLUSTER-RANDOMISED TRIAL (ABSTRACT
150LB)
Euphemia Sibanda
Centre for Sexual Health and HIV AIDS Research, Harare, Zimbabwe
HIV-1 PERSISTS IN CSF CELLS IN HALF OF INDIVIDUALS ON LONG-TERM ART (ABSTRACT
119)
Serena S. Spudich
Yale University, New Haven, USA
LONGITUDINAL TRAJECTORY OF BRAIN VOLUME AND CORTICAL THICKNESS IN PRIMARY INFECTION (ABSTRACT
120)
Ryan Sanford
Montreal Neurological Institute, Montreal, Canada
HIV AND BRAIN ATROPHIC SIGNATURE IN ASYMPTOMATIC NEUROCOGNITIVE IMPAIRMENT (ABSTRACT
121)
Lucette A Cysique
The University of New South Wales, Randwick, NSW, Australia
LONGITUDINAL COGNITIVE OUTCOMES AFTER TREATMENT IN ACUTE HIV INFECTION (ABSTRACT
122)
Phillip Chan
SEARCH, Thai Red Cross AIDS Research Centre, Bangkok , Thailand
IMPACT OF ART REGIMENS ON CSF VIRAL ESCAPE IN HIV-1 INFECTED ADULTS (ABSTRACT
123)
Shibani Sharon Mukerji
Dana Farber Cancer Institute, Boston, MA, USA
SIV REBOUND IN THE SPINAL CORD AFTER STOPPING ART: A NOVEL CNS RESERVOIR (ABSTRACT
124)
Joseph Mankowski
Johns Hopkins University School of Medicine, Baltimore, MD, USA
IDENTIFICATION OF BRAIN INJURY USING A NOVEL DEFINITION OF COGNITIVE IMPAIRMENT (ABSTRACT
125)
Jonathan Underwood
Imperial College London, London, United Kingdom
HEME OXYGENASE-1 POLYMORPHISM ASSOCIATES WITH NEUROIMMUNE ACTIVATION IN HIV SUBJECTS (ABSTRACT
126)
Alexander J Gill
University of Pennsylvania, Philadelphia, PA, USA
THEMED DISCUSSION MODERATOR
Raymond T Chung
Massachusetts General Hospital, Boston, MA, USA
POTENTIAL FOR SERUM MICRO-RNAS TO PREDICT FIBROSIS REGRESSION DURING HBV TREATMENT (ABSTRACT
637)
Eric G Meissner
Medical University of South Carolina, Charleston, SC, USA
HEPATIC EXPRESSION OF HSA-MIR-125A-5P AND FIBROSIS IN OVERT AND OCCULT HBV INFECTION (ABSTRACT
638)
Lorenzo Onorato
University of Campania Luigi Vanvitelli, Naples, Italy
CIRCULATING MICRORNAS IN HIV PATIENTS REVEAL SPECIFIC SIGNATURES FOR LIVER DAMAGE (ABSTRACT
639)
Miguel Angel Martinez
IrsiCaixa Institute for AIDS Research, Badalona, Catalonia, Spain
MIRNA PROFILE OF HCV SPONTANEOUS CLEARANCE INDIVIDUALS SHOW PREVIOUS HCV INFECTION (ABSTRACT
640)
Amanda Fernández-Rodríguez
Spanish National Center for Microbiology, Madrid, Spain
THEMED DISCUSSION MODERATOR
Renee Heffron
University of Washington, Seattle, WA, USA
PREGNANCY INTENTION AND CONTRACEPTIVE USE IN MALAWI'S PMTCT PROGRAM (ABSTRACT
1071)
Deus Thindwa
Imperial College London, London, United Kingdom
|
<< first | < prev
page:
of 2
|
records per page:
next >
| last >>
|
| pages: 1 2
|
presentations:
1 to
50 of
92
|
